FDMT
#2613
4D Molecular Therapeutics, Inc. - Common Stock
13.0 0 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.48%
Monthly Change
-4.69%
6 month change
+29.22%
Year Change
+15.04%
Previous Close
13.3 3
Open
13.3 0
Low
12.8 7
High
13.4 7
Financials
2021
Current report, 12 Aug 2021
4D Molecular Therapeutics, Inc. current report, 12 August 2021
8-K
Quarterly report, Q2 FY2021
4D Molecular Therapeutics, Inc. quarterly report, Q2 FY2021
10-Q
Current report, 18 Jun 2021
4D Molecular Therapeutics, Inc. current report, 18 June 2021
8-K
Current report, 17 May 2021
4D Molecular Therapeutics, Inc. current report, 17 May 2021
8-K
Current report, 13 May 2021
4D Molecular Therapeutics, Inc. current report, 13 May 2021
8-K
Quarterly report, Q1 FY2021
4D Molecular Therapeutics, Inc. quarterly report, Q1 FY2021
10-Q
Current report, 25 Mar 2021
4D Molecular Therapeutics, Inc. current report, 25 March 2021
8-K
2020
Annual report, FY2020
4D Molecular Therapeutics, Inc. annual report, FY2020
10-K
Current report, 15 Dec 2020
4D Molecular Therapeutics, Inc. current report, 15 December 2020
8-K